Delivery Order SPE2DB25D3404-SPE2DB25FUPUC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lidocaine 5% patches (30-count) with a ceiling value of $120,742.35. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX. The award was competitively awarded with no set-aside provisions....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Lidocaine 5% Patch in quantities of 30 units, with a ceiling value of $10,360.64. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award carries an ultimate completion date of August 11, 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lidocaine 5% Patch (30-count units) under a firm fixed-price arrangement with a ceiling value of $1,412.04. The contract, which is not set-aside and was competitively awarded, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This underlying prime IDV, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $1,334.05. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $17,680.85. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by July 23, 2025. The product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s under a firm fixed price contract structure. The award, issued on September 2, 2025, carries a ceiling value of $15,936.84 with an ultimate completion date of September 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units under a firm fixed-price contract valued at $4,631.44. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This contract is a firm fixed price delivery order with a ceiling value of $7,341.46 and an ultimate completion date of September 18, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside competitive procurement action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $8,028.28. This competitively awarded, non-set-aside order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order carries a firm fixed price structure with an ultimate completion date...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,727.04 on August 21, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is a child contract with an ultimate completion date of August 22, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, allowing AmerisourceBergen to compete openly for this...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPUCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30s at a ceiling value of $6,861.83. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order is scheduled for completion by August 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The Lidocaine patch delivery represents one of many pain management pharmaceutical products the company provides through its DLA contract portfolio. As a prime vendor for the Defense Health Agency and other federal healthcare systems, AmerisourceBergen maintains an extensive track record of delivering both brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains in support of Department of Defense healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 8/13/25 |